Weight and mortality in people living with <scp>HIV</scp> and heart failure: Obesity paradox in the era of glucagon‐like peptide 1 (<scp>GLP</scp>‐1) receptor agonists and sodium‐glucose cotransporter‐2 (<scp>SGLT‐2</scp>) inhibitors
Our study found that overall mortality was higher among underweight individuals with both HIV and HF. Among patients with both conditions, GLP-1 RAs and SGLT-2is significantly reduced mortality, with the greatest survival benefit observed in users within the highest BMI categories.
Authors
- Dimitrios Raptis (ORCID: https://orcid.org/0000-0001-9549-053X)
- Luca Biavati (ORCID: https://orcid.org/0000-0001-7870-5754)
- Joshua M. Bock (ORCID: https://orcid.org/0000-0002-0101-0900)
- Vibhor Garg
- Natalia Nazarenko (ORCID: https://orcid.org/0009-0000-3129-1304)
- Paweł Borkowski (ORCID: https://orcid.org/0000-0001-8089-4101)
- Maisha Maliha (ORCID: https://orcid.org/0000-0001-8075-0052)
- Shivang Bhakta (ORCID: https://orcid.org/0000-0001-5757-7108)
- Leonidas Palaiodimos (ORCID: https://orcid.org/0000-0003-4682-5991)
- Coral Vargas‐Pena
- Mandar Kalpesh Shah (ORCID: https://orcid.org/0000-0001-5409-5218)
- Robert Faillace (ORCID: https://orcid.org/0000-0002-9149-7862)
- Matthew Parker
- Ishmum Chowdhury
- Yi‐Yun Chen (ORCID: https://orcid.org/0009-0002-6762-6342)
Institutions
- New York City Health and Hospitals Corporation (US)
- Albert Einstein College of Medicine (US)
- Brown University (US)
Publication Details
- Journal
- HIV Medicine
- Published
- 2025-02-13
- DOI
- https://doi.org/10.1111/hiv.13760
- Citations
- 6
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 13.52